What are CBN and CBG? How are they different from CBD? In this article you will find information about the differences and properties of these cannabinoids.
What is CBN and CBG?
CBN and CBG are chemical compounds found in hemp plants.
CBN (cannabinol) was the first cannabinoid ever isolated from hemp, isolated by American chemist Roger Adams in the 1940s. (2) It has been studied in recent years, particularly in relation to sleep, which is why it is sometimes marketed as a ‘unicannabinoid.’ It is formed from THC (tetrahydrocannabinol) by oxidation when cannabis is exposed to air or light for a long period of time.
CBN has also been shown to have antibacterial activity in laboratory studies, and its association with appetite has been studied in animal models. However, these studies do not yet indicate that CBN products can prevent or treat infections or appetite-related problems in humans. (9,10)
CBG (cannabigerol) on the other hand, there are cannabinoids that appear first in hemp. First comes CBGA, which forms compounds including CBG, THC, CBD and other cannabinoids are later synthesized. (3)
The effects of CBG have been studied in, for example, receptor function, inflammatory responses, bacteria, appetite, and in recent years, stress and anxiety. Much of the research is still preclinical. CBG is not a psychoactive compound, meaning it does not cause an intoxicating effect. (4)
CBG was first identified in 1964 by Raphael Mechoulam and Yehil Gaon. (6)
Both compounds, CBN and CBG, have received increasing attention in cannabis research due to their diverse properties. However, it is important to note that research into the effects and applications of these compounds is still ongoing and more information is needed.
How do CBN and CBG differ from CBD?
CBN, CBG, and CBD are all cannabinoids found in the hemp plant, but they have slightly different chemical structures and effects. A few differences between these compounds are highlighted below:
CBD or cannabidiol does not cause an intoxicating or psychoactive effect. It does not alter consciousness or cause a feeling of euphoria. Also, CBG is not a psychoactive compound, and it does not cause a narcotic effect at all.
CBN is formed when THC breaks down over time through exposure to oxygen, heat, and time. The CBN content in hemp increases as THC breaks down and disappears. Because CBN is formed as a result of the oxidation of THC, it has been found to have mild psychoactive properties. Many CBN products also contain CBD. (1)
CBG (cannabigerol) in its acid form (CBG-A) is the first cannabinoid from which other cannabinoids are also formed.
Research on the biological effects of cannabinoids
The pharmacology of the cannabinoids CBD, CBN and CBG is different, and their mechanisms of action are being actively studied. The amount of research data varies considerably: CBD has been studied in humans significantly more than CBG and CBN.
CBG has been found to interact with several molecular targets, including α2-adrenoreceptors and 5-HT1A receptors, as well as the cannabinoid system. (4) Its antibacterial activity has been observed in laboratory and animal models, and in 2024 the first small placebo-controlled study of the effects of CBG on stress and anxiety in healthy adults was also published. (11,12)
Clinical research on CBN has focused specifically on sleep in recent years. Initial placebo-controlled studies have found some differences in sleep-related measures, but the results have not been entirely consistent. (7,8)
These research findings cannot be directly translated into health or treatment claims for commercial CBG, CBN, or CBD products.

Hemp field in the flowering stage.
Cannabinoid concentrations in hemp
Cannabinoids such as CBN, CBG and CBD occur naturally in hemp in varying amounts. The amounts vary greatly between different varieties. The growing season, environment and other conditions can also affect the concentrations formed in the plant. Over 120 different cannabinoids have been identified in hemp.
CBD is generally more abundant in the hemp plant than CBN or CBG. CBN is formed by the oxidation of THC over time, so it is generally less abundant in young plants. CBG is the main cannabinoid in the early stages of cannabis development, and its presence decreases significantly towards the end of the growing season.
There are many varieties of hemp with different cannabinoid profiles. Nowadays, varieties are also being bred that can contain a certain amount of a particular cannabinoid, being very different from the averages in terms of their cannabinoid profile compared to other common hemp varieties.
What are cannabinoid acids such as CBGA, CBNA and CBDA?
The cannabinoids found in hemp are always initially in acid form, such as CBGA (cannabigerolic acid) and CBDA (cannabidiol acid). The letter A after the name of the cannabinoid refers to its acid form (Acid).
CBGA
CBGA (cannabigerolic acid) and CBNA (cannabinolic acid) are acid forms of cannabinoids that occur in hemp before they are converted to active compounds such as CBG and CBN through acid decarboxylation or oxidation.
CBGA is the acid form of CBG, the first cannabinoid formed in hemp. CBGA is usually present in the cannabis plant in large amounts in the early growth phase, before the plant produces any other cannabinoids. CBGA is converted to other cannabinoids, such as CBDA (cannabidiol acid) or to THCA(tetrahydrocannabinolic acid), over time, through oxidation or carboxylation reactions.
CBNA
CBNA, on the other hand, is the acid form of cannabinol acid that is present in the cannabis plant before it is converted into the active compound, CBN. CBNA is formed from the THCA of the cannabis variety as a result of oxidation. When THCA is exposed to air or light over time, it oxidizes and turns into CBNA. This process can occur when the plant is stored for a long time or poorly stored in non-airtight packaging.
CBNA and CBGA act as precursors from which other active cannabinoids such as CBG and CBN are formed, which are known to affect the body in many different ways.
CBDA
CBDA is a precursor of CBD, or cannabidiol acid. CBDA has been shown to be a powerful antioxidant, antimicrobial and antibacterial.
Summary
CBD, CBN and CBG are the best known cannabinoids, found especially in the leaves and flowers of the hemp plant. These cannabinoids are similar to each other, but each has its own specific properties.
CBGA is a key intermediate in the biosynthesis of cannabinoids, from which THCA, CBDA and CBCA are formed, among others. CBN, on the other hand, is mainly formed from THC. ja THC-A:n hapettumisen seurauksena.
CBN has been studied specifically in relation to sleep, and CBGin relation to stress, anxiety, appetite, inflammatory responses, and antibacterial mechanisms, among others. However, the research evidence for many of the findings regarding CBGand CBN is still based on laboratory and animal studies or initial small human studies, so strong conclusions about their health effects cannot yet be drawn.
Sources
- L Bianco. 2018. GB Sciences Inc. Exploring the Lesser Cannabinoids - The Happy Accident of CBN. https://www.biospace.com/article/releases/exploring-the-lesser-cannabinoids-the-happy-accident-of-cbn/. . Referenced 13.07.2023
- R. Pertwee. 2006. Cannabinoid pharmacology: the first 66 years. Br. J Pharmacol. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760722/. Referenced 14.07.2023
- Tahir M. et al. 2021. The biosynthesis of the cannabinoids. Journal of Cannabis Research. https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-021-00062-4. Referenced 14.07.2023
- RG. Pertwee. 2010. British Journal of Pharmacology. Evidence that the plant cannabinoid cannabigerol is a highly potent a2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist. https://bpspubs.onlinelibrary.wiley.com/doi/pdf/10.1111/j.1476-5381.2009.00515.x. Referenced 14.07.2023
- Gaoni, Y. & Mechoulam, R. 1964. The structure and synthesis of cannabigerol, a new hashish constituent. Proceedings of the Chemical Society, 82. https://doi.org/10.1039/PS9640000073. Referenced 21.09.2026
- M. Lee. 2012. The Discovery of the Endocannabinoid System. The Prop 215 Era. https://www.beyondthc.com/wp-content/uploads/2012/07/eCBSystemLee.pdf. Referenced on 13.07.2023
- Bonn-Miller, M. O. ym. 2024. A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality. Experimental and Clinical Psychopharmacology 32(3), 277–284. https://doi.org/10.1037/pha0000682. Referenced 21.09.2026
- Lavender, I. G. ym. 2026. Cannabinol for Acute Treatment of Insomnia Disorder in a Randomized Placebo-Controlled Crossover Trial. Journal of Sleep Research 35(4), e70284. https://doi.org/10.1111/jsr.70284. Referenced 21.09.2026
- Appendino, G. ym. 2008. Antibacterial Cannabinoids from Cannabis sativa: A Structure–Activity Study. Journal of Natural Products 71(8), 1427–1430. https://doi.org/10.1021/np8002673. Referenced 21.09.2026
- Farrimond, J. A., Whalley, B. J. & Williams, C. M. 2012. Cannabinol and cannabidiol exert opposing effects on rat feeding patterns. Psychopharmacology 223, 117–129. Referenced 21.09.2026
- Cuttler, C., Stueber, A., Cooper, Z. D. & Russo, E. 2024. Acute effects of cannabigerol on anxiety, stress, and mood: a double-blind, placebo-controlled, crossover, field trial. Scientific Reports 14, 16163. https://doi.org/10.1038/s41598-024-66879-0. 21.09.2026
- Farha, M. A. ym. 2020. Uncovering the Hidden Antibiotic Potential of Cannabis. ACS Infectious Diseases 6(3), 338–346. https://doi.org/10.1021/acsinfecdis.9b00419. Referenced 21.09.2026
Written by the experts at Hamppumaa.
Last reviewed: September 21, 2026




